# Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects

> **NCT06089837** · PHASE1 · COMPLETED · sponsor: **EicOsis Human Health Inc.** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** EC5026 oral tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT06089837
- **Lead sponsor:** EicOsis Human Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-28
- **Primary completion:** 2024-03-13
- **Final completion:** 2024-05-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06089837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06089837, "Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06089837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*